Resting EEG and ERPs findings in methadone-substituted opiate users: a review

Garrido MJ, Trocóniz IF (1999) Methadone: a review of its pharmacokinetic/pharmacodynamic properties. J Pharmacol Toxicol Methods 42(2):61–66 Marsch LA (1998) The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 93(4):515–532 Gibson DR, Flynn NM, McCarthy JJ (1999) Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. Aids 13(14):1807–1818 Wang GY, Wouldes TA, Russell BB (2013) Methadone maintenance treatment and cognitive function: a systematic review. Curr Drug Abuse Rev 6(3):220–230 Prosser J, Cohen LJ, Steinfeld M, Eisenberg D, London ED, Galynker II (2006) Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depen 84(3):240–247 PubMed PMID: 2006420273 Verdejo A, Toribio I, Orozco C, Puente KL, Perez-Garcia M (2005) Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depen 78(3):283–288 PubMed PMID: 2005225732 Darke S, Sims J, McDonald S, Wickes W (2000) Cognitive impairment among methadone maintenance patients. Addiction 95(5):687–695 Mintzer MZ, Stitzer ML (2002) Cognitive impairment in methadone maintenance patients. Drug Alcohol Depen 67(1):41–51 Rapeli P, Fabritius C, Kalska H, Alho H (2009) Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individuals. Subst Abuse Treat Pr 4(6):1–15 Pirastu R, Fais R, Messina M, Bini V, Spiga S, Falconieri D et al (2006) Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug Alcohol Depen 83(2):163–168 (PubMed PMID: Peer Reviewed Journal: 2006-07783-009) Rapeli P, Fabritius C, Alho H, Salaspuro M, Wahlbeck K, Kalska H (2007) Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls. BMC Clin Pharmacol 7(1):5 Davis PE, Liddiard H, McMillan TM (2002) Neuropsychological deficits and opiate abuse. Drug Alcohol Depen 67(1):105–108 (PubMed PMID: Peer Reviewed Journal: 2002-17450-011) Soyka M, Lieb M, Kagerer S, Zingg C, Koller G, Lehnert P et al (2008) Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial. J Clin Psychopharmacol 28(6):699–703 Appel PW (1982) Sustained attention in methadone patients. Subst Use Misuse 17:1313–1327 Appel P, Gordon N (1976) Digit-symbol performance in methadone-treated ex-heroin addicts. Am J Psychiatry 133:1337–1340 Specka M, Finkbeiner T, Lodemann E, Leifert K, Kluwig J, Gastpar M (2000) Cognitive-motor performance of methadone-maintained patients. Eur Addict Res 6:8–19 Grevert P, Masover B, Goldstein A (1977) Failure of methadone and levomethadyl acetate (levo-alpha-acetylmethadol, LAAM) maintenance to affect memory. Arch Gen Psychiatry 34(7):849–853 (PubMed PMID: Peer Reviewed Journal: 1978-12936-001) Ersche KD, Roiser JP, Clark L, London M, Robbins TW, Sahakian BJ (2005) Punishment induces risky decision-making in methadone-maintained opiate users but not in heroin users or healthy volunteers. Neuropsychopharmacology 30(11):2115–2124 Gordon NB (1970) Reaction-times of methadone treated ex heroin addicts. Psychopharmacology. 16:337–344 Rothenberg S, Meyer RE, Rauss B, Gross K (1977) Performance differences between addicts and non-addicts. Psychopharmacology 52(3):299–306 Corradini PL, Persinger MA (2014) Spectral power, source localization and microstates to quantify chronic deficits from ‘mild’ closed head injury: correlation with classic neuropsychological tests. Brain Inj 2014(28):1317–1327 Klimesch W, Vogt F, Doppelmayr M (1999) Interindividual differences in alpha and theta power reflect memory performance. Intelligence 27(4):347–362 Ray W, Cole H (1985) EEG alpha activity reflects attentional demands, and beta activity reflects emotional and cognitive processes. Science 228(4700):750–752 Barry RJ, Clarke AR, Johnstone SJ, Magee CA, Rushby JA (2007) EEG differences between eyes-closed and eyes-open resting conditions. Clin Neurophysiol 118(12):2765–2773 Alexander DM, Trengove C, Wright JJ, Boord PR, Gordon E (2006) Measurement of phase gradients in the EEG. J Neurosci Methods 156(1–2):111–128 Klimesch W, Sauseng P, Hanslmayr S (2007) EEG alpha oscillations: the inhibition–timing hypothesis. Brain Res Rev 53:63–88 Gritz ER, Shiffman SM, Jarvik ME, Haber J, Dymond AM, Coger R et al (1975) Physiological and psychological effects of methadone in man. Arch Gen Psychiatry 32(2):237–242 Feinstein B, Hanley J (1975) EEG findings in heroin addicts during induction and maintenance on methadone. Electroencephalogr Clin Neurophysiol 39(1):96–99 Fingelkurts AA, Fingelkurts AA, Kivisaari R, Autti T, Borisov S, Puuskari V et al (2007) Composition of EEG oscillations and their temporal characteristics. Int J Psychophysiol 64:130–140 Fingelkurts AA, Fingelkurts AA, Kivisaari R, Autti T, Borisov S, Puuskari V et al (2009) Methadone restores local and remote EEG functional connectivity in opioid. Int J Neurosci 119(9):1469–1493 Gorricho D, Valdizanuson JR (2008) QEEG mapping and methadone. Eur J Psychiat Online 22(1):29–37 Kay DC (1975) Human sleep and EEG through a cycle of methadone dependence. Electroencephalogr Clin Neurophysiol 38(1):35–43 Lenn NJ, Senay EC, Renault PF, Deuel RK (1976) Neurological assessment of patients on prolonged methadone maintenance. Drug Alcohol Depen 1(4):305–311 Martin WR, Jasinski DR, Haertzen CA, Kay DC, Jones BE, Mansky PA et al (1973) Methadone–a reevaluation. Arch Clin Neuropsychol 28(2):286–295 Wang GY, Kydd R, Wouldes TA, Jensen M, Russell BR (2015) Changes in resting EEG following methadone treatment in opiate addicts. Clin Neurophysiol 126:943–950 Danion JM, Weingartner H, File SE, Jaffard R, Sunderland T, Tulving E et al (1993) Pharmacology of human memory and cognition: illustrations from the effects of benzodiazepines and cholinergic drugs. J Psychopharmacol 7(4):371–377 Oades R, Dittmann-Balcar A, Schepker R, Eggers C, Zerbin D (1996) Auditory event-related potentials (ERPs) and mismatch negativity (MMN) in healthy children and those with attentiondeficitor Tourettic symptoms. Biol Psychol 43:163–185 Laurent A, Garcia-Larréa L, d’Amato T, Bosson J, Saoud M, Marie-Cardine M (1999) Auditory event-related potentials and clinical scores in unmedicated schizophrenic patients. Psychiatry Res 86:229–238 Llinás R, Ribary U (1993) Coherent 40-Hz oscillation characterizes dream state in humans. Proceed Natl Acad Sci 90(5):2078–2081 Boutros NN, Torello M, McGlashan TH (2003) Electrophysiological Aberrations in Borderline Personality Disorder: State of the Evidence The Journal of Neuropsychiatry and Clinical Neurosciences. 15:145–154 Markand ON (2003) Pearls, perils, and pitfalls in the use of the electroencephalogram. Semin Neurol 23(1):7–46 Wolff K, Rostami-Hodjegan A, Hay AWM, Raistrick D, Tucker G (2000) Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility. Addiction 95(12):1771–1783 Ceballos NA, Bauer L, Houston R (2009) Recent EEG and ERP findings in substance abusers. Clin EEG Neurosci 40(2):122–128 Halgren E, Marinkovic K, Chauvel P (1998) Generators of the late cognitive potentials in auditory and visual oddball tasks. Electroencephalogr Clin Neurophysiol 106(2):156–164 Mulert C, Pogarell O, Hegerl U (2010) Event-related potentials in psychiatry and clinical pharmacology:Basics, applicationa and relationship to fMRI. In: Drinkenburg WHIM, Ruigt GSF, Jobert M (eds) Essentials and applications of EEG research in preclinical and clinical pharmacology. IPEG, Belgium, pp 165–172 Tecce JJ, Cole JO, Mayer J, Lewis DC (1979) Methadone effects on brain functioning and Type A and B CNV shapes. Psychopharmacology 65(1):21–25 Nagai Y, Critchley HD, Featherstone E, Fenwick PBC, Trimble MR, Dolan RJ (2004) Brain activity relating to the contingent negative variation: an fMRI investigation. NeuroImage 21(4):1232–1241 Pritchard W, Sokhadze E, Houlihan M (2004) Effects if nicotine and smoking on event-related potentials: a reivew. Nicotine Tob Res. 6(6):961–984 Di Russo F, Pitzalis S, Spitoni G, Aprile T, Patria F, Spinelli D et al (2005) Identification of the neural sources of the pattern-reversal VEP. NeuroImage 24(3):874–886 Bauer L (1998) Effects of chronic opioid dependence and HIV-1 infection on pattern shift visual evoked potentials. Drug Alcohol Depen 50(2):147–155 Patel S, Azzam P (2005) Characterization of N200 and P300: selected studies of the event-related potential. Int J Med Sci 2(4):147–154 Wickens C, Karmer A, Vanasse L, Donchin E (1983) The performance of concurrent tasks:a psychophysiological analysis of the reciprocity of inofrmation processsing resources. Science 221:1080–1082 Polich J (1986) Attention, probability, and task demands as determinants of P300 latency from auditory stimuli. Electroencephalogr Clin Neurophysiol 63(3):251–259 Alexander JE, Bauer LO, Kuperman S, Morzorati S, O’Connor SJ, Rohrbaugh J et al (1996) Hemispheric differences for P300 amplitude from an auditory oddball task. Int J Psychophysiol 21(2–3):189–196 Attou A, Figiel C, Timsit-Berthier M (2001) Opioid addiction: P300 assessment in treatment by methadone substitution. Neurophysiol Clin 31(3):171–180 Kouri E, Lukas S, Mendelson J (1996) P300 assessment of opiate and cocaine users: effects of detoxification and buprenorphine treatment. Biol Psychoiatry 40:617–628 Muller BW, Specka M, Steinchen N, Zerbin D, Lodemann E, Finkbeiner T et al (2007) Auditory target processing in methadone substituted opiate addicts: The effect of nicotine in controls. BMC Psychiatry 7:1–9 (PubMed PMID: Peer Reviewed Journal: 2008-10167-001) Yang L, Xu Q, Li S, Zhao X, Ma L, Zheng Y, et al. (2015) The effects of methadone maintenance treatment on heroin addicts with response inhibition function impairments: evidence from event-related potentials. J Food Drug Anal (in Press) Hart CL, Marvin CB, Silver R, Smith EE (2012) Is cognitive functioning impaired in methamphetamine users [quest] a critical review. Neuropsychopharmacology 37(3):586–608 Hart CL, Ilan AB, Gevins A, Gunderson EW, Role K, Colley J et al (2010) Neurophysiological and cognitive effects of smoked marijuana in frequent users. Pharmacol Biochem Behav 96(3):333–341 Gevins A, Ilan AB, Jiang A, Sam-Vargas L, Baum C, Chan CS (2011) Combined neuropsychological and neurophysiological assessment of drug effects on groups and individuals. J Psychopharmcol 25:1062–1075 Kenemans JL, Kahkonen S (2011) How Human Electrophysiology Informs Psychopharmacology: from Bottom-up Driven Processing to Top-Down Control. Neuropsychopharmacology 36(1):26–51